News
GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...
GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...
GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults ...
4d
Pharmaceutical Technology on MSNBharat Biotech acquires licence for GSK’s Shigella vaccine developmentThe partnership includes support for the design of the Phase III trial and assistance in securing external funding.
Blood cancer patients in England will be the first in the world to be offered a 'Trojan horse' drug. Thousands of patients ...
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
This Original Lifetime Movie, "Pretty Hurts," airs June 28, at 8 p.m.
What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...
IPV Vaccines Market Set to Expand at CAGR of 8.7% Through 2032 | Sanofi Pasteur, GlaxoSmithKline plc
The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results